Introduction
Sexual health is generally undervalued and undertreated, despite the possibility that a cancer patient may experience sexual dysfunction for the duration of their illness. Since patients are unlikely to bring up sexual issues, it is best to anticipate sexual problems and aggressively screen them. Sexual dysfunction brought on by cancer can have multiple causes, and to customize the right course of treatment for each patient, it is crucial to comprehend the underlying etiologies. The various factors that may be implicated in male sexual dysfunction linked to various tumors are reviewed in this article. A serious health issue that significantly affects sexual function and quality of life is cancer.
What Is Sexual Dysfunction?
An issue that can arise at any stage of the sexual response cycle is sexual dysfunction. It keeps them from getting joy from having sex. Traditionally, the phases of the sexual response cycle are stimulation, plateau, orgasm, and resolution. Arousal and desire are both a part of the sexual response's excitement phase. It is crucial to understand that women do not always experience these stages in that sequence. Even though evidence indicates that sexual dysfunction is widespread, many people find it uncomfortable to discuss. However, they should discuss their worries with their spouses and healthcare providers because there are therapy choices available.
What Are the Types of Sexual Dysfunction?
In general, there are four categories of sexual dysfunction:
-
Unwanted sexual desire or interest in sex.
-
The absence of bodily arousal or excitement during sexual engagement.
-
Difficulties related to orgasm a postponed or absent climax.
-
Analgesia is discomfort during sexual activity.
Who Is Affected by Sexual Dysfunction?
Although sexual dysfunction can afflict people of any age, it is more prevalent in those over 40 due to the fact that it is frequently linked to aging-related loss in health.
What Are the Etiology of Sexual Dysfunction in Cancer Patients?
Sexual dysfunction associated with cancer can have multiple causes, and diagnosing the underlying aetiologies is crucial to determining the best course of action for each patient.
1.Psychological Factors
Patients may experience depression, anxiety about treatment side effects or death, impending erectile dysfunction fears, declines in self-esteem, or disruptions to a long-term emotional and sexual balance with their partner during the early stages of cancer diagnosis and treatment. Starting with the diagnosis and treatment planning phases, libido is negatively impacted. If there are sexually oriented thoughts or desires, they might lead to shame and increased repression of sexuality. Treatment for cancer can cause psychological stress in addition to physical changes, making it more difficult to maintain a positive body image and to maintain one's perceived sexual attractiveness. The goal is early complete identification and intervention of sexual dysfunction because untreated treatment-related erectile dysfunction might prolong the loss of self-esteem and sense of manhood. Particularly while receiving cancer treatment, patients may have irrational worries about hurting themselves or their partner during sexual activity.
2. Physical Symptoms
There are physical symptoms associated with cancer that can negatively impact one's ability to conceive. Fatigue, gastrointestinal symptoms (diarrhea, nausea), symptoms related to the urinary tract, sleep disturbances, and pain are examples of general symptoms. Physical symptoms can be made worse by surgery, radiation therapy, chemotherapy, combined-modality treatment, biological and hormonal therapies, and more. If sexual dysfunction is to be effectively managed, uncontrolled symptoms must be addressed since they negatively impact erectile function, sexual interest, and desire.
3. Drug-Induced Sexual Dysfunction
Cancer patients may experience sexual dysfunction due to physical symptoms, but the negative impact of medications on sexual function may make symptom control even more difficult. Chronic opioid use for pain management in cancer patients has been shown to worsen depression, exhaustion, and sexual dysfunction in addition to causing hypogonadism in men. When psychiatric medications are used to treat depression and anxiety in cancer patients, the libido, erection, ejaculation, and orgasmic function may all be negatively impacted.
4. Prostate Cancer And Sexual Dysfunction
Men are most likely to develop prostate cancer, with an approximate lifetime likelihood of 18 percent and a lifetime probability of 3 percent respectively, making prostate cancer the most common cancer in the world. Radical prostatectomy, external-beam radiation, and brachytherapy are among the treatment options for localized prostate cancer. In systemic disease, androgen-deprivation hormonal therapy is utilized as a neoadjuvant treatment in conjunction with radiation therapy; in cases of severe disease, chemotherapy may be used.
All of these therapeutic approaches aside from cautious waiting have a negative impact on health-related quality of life and sexual function. Following prostate cancer therapy, there are several types of sexual dysfunction that can arise, such as decreased interest in and frequency of sexual activity, decreased enjoyment of it, diminished confidence, and mainly self-esteem.
Conclusion
There is a wide range in the proportion of men who have sexual dysfunction as a result of testicular cancer treatment. A third of men typically struggle with one or more of the following: decreased desire for sex, orgasmic dysfunction, ejaculation disorder, decreased sexual activity, and discontent with sex life. Regardless of the type of treatment they receive, testicular cancer patients overall have a markedly higher incidence of ejaculation disorder and orgasmic dysfunction when compared to healthy controls. The only treatments that have been demonstrated to be able to produce a particular and lasting sexual dysfunction, namely loss of ejaculation ability (retrograde ejaculation), are the dissection of lymph nodes or removal of the residual retroperitoneal tumor mass. In particular, ejaculation disorder and issues related to desire and orgasm are observed during radiation therapy. A worldwide impact on sexuality is reported during chemotherapy, but it seems to be transient. Particularly noticeable during surveillance are decreased libido and orgasmic dysfunction. No long-term effects have been noted, specifically when it comes to radiation, chemotherapy, or surveillance.
